ATA208987A - IMMORTALIZED CELL LINE, METHOD FOR THEIR PRODUCTION AND METHOD FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES, AND DIAGNOSTIC METHODS AND MEANS - Google Patents

IMMORTALIZED CELL LINE, METHOD FOR THEIR PRODUCTION AND METHOD FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES, AND DIAGNOSTIC METHODS AND MEANS

Info

Publication number
ATA208987A
ATA208987A AT0208987A AT208987A ATA208987A AT A208987 A ATA208987 A AT A208987A AT 0208987 A AT0208987 A AT 0208987A AT 208987 A AT208987 A AT 208987A AT A208987 A ATA208987 A AT A208987A
Authority
AT
Austria
Prior art keywords
production
cell line
monoclonal antibodies
diagnostic methods
immortalized cell
Prior art date
Application number
AT0208987A
Other languages
German (de)
Other versions
AT398080B (en
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of ATA208987A publication Critical patent/ATA208987A/en
Application granted granted Critical
Publication of AT398080B publication Critical patent/AT398080B/en

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • AIDS & HIV (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT0208987A 1986-08-20 1987-08-20 IMMORTALIZED CELL LINE, METHOD FOR THEIR PRODUCTION AND METHOD FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES, AND DIAGNOSTIC METHODS AND MEANS AT398080B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (2)

Publication Number Publication Date
ATA208987A true ATA208987A (en) 1994-01-15
AT398080B AT398080B (en) 1994-09-26

Family

ID=27366600

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0208987A AT398080B (en) 1986-08-20 1987-08-20 IMMORTALIZED CELL LINE, METHOD FOR THEIR PRODUCTION AND METHOD FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES, AND DIAGNOSTIC METHODS AND MEANS

Country Status (28)

Country Link
JP (1) JPS6485928A (en)
KR (1) KR920008744B1 (en)
AT (1) AT398080B (en)
AU (1) AU616156B2 (en)
BE (1) BE1000811A4 (en)
CH (1) CH675728A5 (en)
CS (1) CS275838B6 (en)
DE (1) DE3727703A1 (en)
DK (1) DK433087A (en)
ES (1) ES2010727A6 (en)
FI (1) FI873553A (en)
FR (1) FR2603107B1 (en)
GB (1) GB2196634B (en)
GR (1) GR871298B (en)
HU (1) HU214439B (en)
IE (1) IE60671B1 (en)
IL (1) IL83580A (en)
IT (1) IT1222518B (en)
LU (1) LU86972A1 (en)
NL (1) NL8701950A (en)
NO (2) NO300462B1 (en)
NZ (1) NZ221440A (en)
OA (1) OA08652A (en)
PL (1) PL155084B1 (en)
PT (1) PT85567B (en)
SE (1) SE506025C2 (en)
YU (1) YU152587A (en)
ZW (1) ZW15487A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
ATE122237T1 (en) * 1987-05-29 1995-05-15 Tanox Biosystems Inc HIV-1 NEUTRALIZING MONOCLONAL ANTIBODIES.
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
EP0400076B1 (en) * 1988-01-26 1996-05-15 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce A synthetic antigen evoking anti-hiv response
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (en) * 1988-06-06 1992-04-10 Pasteur Institut PEPTIDES HAVING PROTECTIVE PROPERTIES OF A PATHOGENIC VIRUS OF THE HIV TYPE IN SENSITIVE CELLS
JPH04502760A (en) * 1988-10-03 1992-05-21 レプリゲン・コーポレーション Novel HIV proteins and peptides effective in the diagnosis, prevention and treatment of AIDS
CA2025481A1 (en) * 1989-09-19 1991-03-20 Peter J. Kniskern Vaccine for aids and hepatitis b
SE9000333D0 (en) * 1990-01-31 1990-01-31 Britta Wahren MONOCLONAL ANTIBODY
SE468168B (en) * 1990-02-20 1992-11-16 Replico Medical Ab HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS
JPH03271233A (en) * 1990-03-19 1991-12-03 Inst Pasteur Inducement of protective action against virus infection by synergism between peptides cor- responding to virus envelope glycoprotein and neutral epitope of its glycoprotein
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (en) * 1991-09-30 1993-11-22 Nitto Denko Corp Hiv-related cyclic peptide and adsorption material obtained by immobilizing the same
CA2132516A1 (en) * 1992-03-27 1993-10-14 Anders J. Andersen Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis
CN103450345B (en) 2005-12-09 2016-04-20 伟克特斯生物系统有限公司 VIP fragment and methods for using them
EP2323233B1 (en) 2008-09-02 2017-10-11 NGK Spark Plug Co., Ltd. Spark plug

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
EP0387914B1 (en) * 1984-10-18 1993-08-04 Institut Pasteur Envelope antigens of the human immuno-deficiency virus, and their applications
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
CA1341482C (en) * 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
DE3650011T2 (en) * 1985-04-08 1994-11-17 Genetic Systems Corp EXPRESSION AND DIAGNOSIS WITH GAG-CODED PEPTIDES THAT ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES AGAINST LAV.
FI861626A (en) * 1985-04-19 1986-10-20 Hoffmann La Roche FOERVAERVAT IMMUNBRISTSYNDROM (AIDS) RELATERAT VIRALT REKOMBINANT HELJEPROTEIN SAMT ETT TESTFOERFARANDE FOER AIDS.
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
JPS63501716A (en) * 1985-10-24 1988-07-14 サウスウエスト・ファウンデ−ション・フォア・バイオメディカル・リサ−チ Synthetic peptides and their use for diagnosis of AIDS and ARC and vaccine injections
JP2837669B2 (en) * 1985-11-07 1998-12-16 プレジデント アンド フエロウズ オブ ハ−バ−ド カレツジ T-cell lymphotropic virus protein and its analysis
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
EP0525828A3 (en) * 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
AU592258B2 (en) * 1986-12-30 1990-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins

Also Published As

Publication number Publication date
YU152587A (en) 1992-09-07
NO873495D0 (en) 1987-08-19
OA08652A (en) 1988-11-30
SE8703225D0 (en) 1987-08-19
GB2196634A (en) 1988-05-05
IE60671B1 (en) 1994-08-10
DK433087A (en) 1988-02-21
IT8721678A0 (en) 1987-08-19
CS8706136A2 (en) 1990-08-14
PT85567B (en) 1991-02-08
PL267401A1 (en) 1988-07-21
FR2603107B1 (en) 1992-04-24
KR920008744B1 (en) 1992-10-09
SE506025C2 (en) 1997-11-03
HU214439B (en) 1998-03-30
DE3727703A1 (en) 1988-05-05
AU616156B2 (en) 1991-10-24
FR2603107A1 (en) 1988-02-26
CS275838B6 (en) 1992-03-18
IE872219L (en) 1988-02-20
IT1222518B (en) 1990-09-05
DK433087D0 (en) 1987-08-19
NO934897D0 (en) 1993-12-29
NO934897L (en) 1993-12-29
FI873553A0 (en) 1987-08-17
JPS6485928A (en) 1989-03-30
NL8701950A (en) 1988-03-16
IL83580A0 (en) 1988-01-31
NO873495L (en) 1988-02-22
KR890002547A (en) 1989-04-10
GB2196634B (en) 1991-05-15
SE8703225L (en) 1988-02-21
IL83580A (en) 1992-11-15
NO300462B1 (en) 1997-06-02
FI873553A (en) 1988-02-21
PL155084B1 (en) 1991-10-31
LU86972A1 (en) 1988-03-02
BE1000811A4 (en) 1989-04-11
NO302176B1 (en) 1998-02-02
GR871298B (en) 1988-01-12
ES2010727A6 (en) 1989-12-01
PT85567A (en) 1987-09-01
CH675728A5 (en) 1990-10-31
AT398080B (en) 1994-09-26
ZW15487A1 (en) 1988-09-14
GB8719587D0 (en) 1987-09-23
AU7720187A (en) 1988-05-19
NZ221440A (en) 1991-11-26
HUT44619A (en) 1988-03-28

Similar Documents

Publication Publication Date Title
ATA208987A (en) IMMORTALIZED CELL LINE, METHOD FOR THEIR PRODUCTION AND METHOD FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES, AND DIAGNOSTIC METHODS AND MEANS
DE3788058D1 (en) CELL TOXIC ANTIBODY COMPLEX AND METHOD FOR THE PRODUCTION THEREOF.
DE3675961D1 (en) SEPARATION MEMBRANE AND METHOD FOR THEIR PRODUCTION.
DE3788026D1 (en) Method and device for culturing cells.
DE3583721D1 (en) POROESE FILMS AND METHOD FOR THEIR PRODUCTION.
DE3780560D1 (en) PROBE AND METHOD FOR THE PRODUCTION THEREOF.
DE3878326T2 (en) ARTIFICATION OF THE MEMBRANE TYPE AND METHOD FOR THEIR USE.
DE3871416D1 (en) MIXING DEVICE AND METHOD FOR THEIR PRODUCTION.
DE3581765D1 (en) ELECTROCHEMICAL METHOD AND DEVICE FOR PRODUCTION.
DE3874275D1 (en) COLLECTORS AND METHOD FOR THEIR PRODUCTION AND USE.
DE3881128D1 (en) SEMI-STIFF LUGGAGE BOWL AND METHOD FOR THEIR PRODUCTION.
DE3783396D1 (en) METHOD FOR PRODUCING BISHOMO GAMMA LINOLIC ACID AND EICOSAPENTIC ACID.
ATA328286A (en) CELL LINES AND METHOD FOR PRODUCING HUMAN MONOCLONAL ANTIBODIES AND KIT AND METHOD FOR DETERMINING THE PRESENCE OF P.AERUGINOSA
DE3668782D1 (en) ARTIFICIAL LUNG OF THE MEMBRANE TYPE AND METHOD FOR THE PRODUCTION THEREOF.
DE3770853D1 (en) CELL SEPARATOR AND METHOD FOR THE PRODUCTION THEREOF.
DE3587268D1 (en) METHOD FOR ISOLATING THE MYCOBACTERIAL ANTIGENS-A60 AND THE USE OF THIS ANTIQUE FOR PRODUCING IMMUNOLOGICAL REAGENTS AND IN IMMUNOLOGICAL TEST PROCEDURES.
ATA43587A (en) METHOD FOR PRODUCING A MONOCLONAL ANTIBODY AND METHOD FOR DETECTING MALIGNAL CELLS
DE3578375D1 (en) BONE CEMENT AND METHOD FOR THE PRODUCTION THEREOF.
DE3579765D1 (en) STRUCTURAL CONCRETE PART AND METHOD FOR THE PRODUCTION THEREOF.
DE3583875D1 (en) METHOD FOR PRODUCING SPHERICAL WHOLE BLOOD ERYTHROCYTES AND FIXING THEREOF.
DE3677349D1 (en) ARTIFICIAL LUNG OF THE MEMBRANE TYPE AND METHOD FOR THE PRODUCTION THEREOF.
DE3577213D1 (en) LUCIFERASE-CARRYING MEMBRANE FOR DOSING ATP AND METHOD FOR THE PRODUCTION THEREOF.
ATA172784A (en) SEALING MEMBRANE AND METHOD FOR THEIR PRODUCTION
AT399885B (en) METHOD FOR PRODUCING CELL LINES THAT PRODUCE MONOCLONAL ANTIBODIES
DE3776284D1 (en) HYDROLASE AND METHOD FOR THEIR PRODUCTION.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties